Physiological roles of corticotropin-releasing hormone receptor type 2

被引:41
作者
Hashimoto, K
Makino, S
Asaba, K
Nishiyama, M
机构
[1] Kochi Med Sch, Dept Internal Med 2, Nanko Ku, Kochi 7838505, Japan
[2] Osaka Gyomeikan Hosp, Dept Internal Med, Osaka 5540022, Japan
关键词
D O I
10.1507/endocrj.48.1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recent investigations of the physiological roles of CRH-R2 are reviewed and summarized in Fig. 5. VMH CRH-R2 is more important than CRH-R1 in mediating anorexic effect of CRH or urocortin (UCN) and stress-induced reduction of food intake. CRH-R2 mediates a central anxiolytic response, opposing the anxiogenic effect of CRH mediated by CRH-R1. Hippocampal CRH-R1 mediates stress-induced enhancement of learning, while CRH-R2 in the lateral intermediate septum may act to impair learning. CRH-R1 mediates CRH-induced blood pressure elevation, while peripheral CRH-R2 mediates the hypotensive effect of systemically administered UCN and CRH. It is likely that CRH-R2 does not play an important role in hypothalamic-pituitary adrenal axis regulation, though it has been reported that CRH-R2-deficient mice showed hyper-response of ACTH and corticosterone. Peripheral CRH-R2 mediates UCN-induced mast cell degranulation, vascular permeability, and abdominal surgery-induced gastric stasis. These recent investigations have revealed that the existence of two CRH receptors, which mediate some opposite effects, provides the CRH and UCN systems a high flexibility and dynamic role in the adaptation of the body to environmental challenge.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 58 条
[1]   Regulation of type-2 corticotropin-releasing hormone receptor mRNA in rat heart by glucocorticoids and urocortin [J].
Asaba, K ;
Makino, S ;
Nishiyama, M ;
Hashimoto, K .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2000, 36 (04) :493-497
[2]   Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress [J].
Bale, TL ;
Contarino, AB ;
Smith, GW ;
Chan, R ;
Gold, LH ;
Sawchenko, PE ;
Koob, GF ;
Vale, WW ;
Lee, KF .
NATURE GENETICS, 2000, 24 (04) :410-414
[3]   CORTICOTROPIN-RELEASING FACTOR (CRF) BINDING-PROTEIN - A NOVEL REGULATOR OF CRF AND RELATED PEPTIDES [J].
BEHAN, DP ;
DESOUZA, EB ;
LOWRY, PJ ;
POTTER, E ;
SAWCHENKO, P ;
VALE, WW .
FRONTIERS IN NEUROENDOCRINOLOGY, 1995, 16 (04) :362-382
[4]   CRF AND RESTRAINT-STRESS DECREASE EXPLORATORY-BEHAVIOR IN HYPOPHYSECTOMIZED MICE [J].
BERRIDGE, CW ;
DUNN, AJ .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1989, 34 (03) :517-519
[5]  
Bittencourt JC, 1999, J COMP NEUROL, V415, P285
[6]   Chronic effects of a nonpeptide corticotropin-releasing hormone type I receptor antagonist on pituitary-adrenal function, body weight, and metabolic regulation [J].
Bornstein, SR ;
Webster, EL ;
Torpy, DJ ;
Richman, SJ ;
Mitsiades, N ;
Igel, M ;
Lewis, DB ;
Rice, KC ;
Joost, HG ;
Tsokos, M ;
Chrousos, GP .
ENDOCRINOLOGY, 1998, 139 (04) :1546-1555
[7]   INTRAVENTRICULAR CORTICOTROPIN-RELEASING FACTOR ENHANCES BEHAVIORAL-EFFECTS OF NOVELTY [J].
BRITTON, DR ;
KOOB, GF ;
RIVIER, J ;
VALE, W .
LIFE SCIENCES, 1982, 31 (04) :363-367
[8]   CORTICOTROPIN-RELEASING FACTOR RECEPTOR ANTAGONIST - EFFECTS ON THE AUTONOMIC NERVOUS-SYSTEM AND CARDIOVASCULAR FUNCTION [J].
BROWN, MR ;
GRAY, TS ;
FISHER, LA .
REGULATORY PEPTIDES, 1986, 16 (3-4) :321-329
[9]   CORTICOTROPIN-RELEASING FACTOR - ACTIONS ON THE SYMPATHETIC NERVOUS-SYSTEM AND METABOLISM [J].
BROWN, MR ;
FISHER, LA ;
SPIESS, J ;
RIVIER, C ;
RIVIER, J ;
VALE, W .
ENDOCRINOLOGY, 1982, 111 (03) :928-931
[10]   Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2 [J].
Coste, SC ;
Kesterson, RA ;
Heldwein, KA ;
Stevens, SL ;
Heard, AD ;
Hollis, JH ;
Murray, SE ;
Hill, JK ;
Pantely, GA ;
Hohimer, AR ;
Hatton, DC ;
Phillips, TJ ;
Finn, DA ;
Low, MJ ;
Rittenberg, MB ;
Stenzel, P ;
Stenzel-Poore, MP .
NATURE GENETICS, 2000, 24 (04) :403-409